Home
Resources
Publications
Sodium Iodide I 131

Sodium Iodide I 131

PMID: 30000623

Abstract:

Information in this record refers to the use of sodium iodide I 131 as a diagnostic and therapeutic agent. The use of I 131 is contraindicated during lactation.[1] Breastfeeding should be discontinued permanently for this child after administration of sodium iodide I 131 in a dose of 0.01 MBq (0.004 mCi) or greater to a nursing mother.[2][3][4][5][6][7][8][9] Ceasing breastfeeding at least 4 weeks before receiving a therapeutic dose of sodium iodide I 131 is recommended to reduce the radiation dose to the breasts and the risk of milk leakage that can contaminate clothing with radioactive iodine.[4][10][11] The American Thyroid Association recommends using I 123 or Tc99m pertechnetate scans for diagnosis of hyperthyroidism in nursing mothers.[1]
Parents should refrain from close contact with their infants after therapeutic iodine 131 administration. The exact duration depends on the dose administered, condition being treated, and source of the recommendation.[2][12][13] Recommended times range from 15 to 27 days after hyperthyroidism treatment, 16 to 24 days after ablation of thyroid cancer, and 4 to 5 days after follow-up therapy of thyroid ablation therapy.[13]
Nursing mothers should not work with substances containing I 131 in their workplace.[14]

Chemicals Related in the Paper:

Catalog Number	Product Name	CAS Number	Price
AP7681825	Sodium iodide	7681-82-5	Price
LS72735	i-Butylammonium iodide		Price
LS72737	i-Propylammonium iodide		Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: